2025
Machine Learning Risk Stratification for Older Breast Cancer Survivors: Clinical Care Implications
Wheeler S, Rotter J, Spees L, Biddell C, Trogdon J, Alfano C, Mayer D, Dinan M, Nekhlyudov L, Birken S. Machine Learning Risk Stratification for Older Breast Cancer Survivors: Clinical Care Implications. Health Services Research 2025, e70005. PMID: 40671264, DOI: 10.1111/1475-6773.70005.Peer-Reviewed Original ResearchBreast cancer survivorsAdverse health outcomesCancer survivorsHealth outcomesCancer-specific deathOlder breast cancer survivorsClinical care implicationsRisk prediction algorithmsAdverse outcomesHigh riskSEER-CAHPSRisk of all-cause deathPrimary careSurvivorship outcomesClinical risk prediction algorithmsCare implicationsClaims dataAll-cause deathCohen's kappaEnd ResultsSurvivorsCancer recurrenceFollow-up periodLow riskCare
2020
Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL).
Brander D, Oeffinger K, Greiner M, Dinan M. Prevalence, screening, treatment, and complications of osteoporosis and osteopenia in Medicare patients with chronic lymphocytic leukemia (CLL). Journal Of Clinical Oncology 2020, 38: e24050-e24050. DOI: 10.1200/jco.2020.38.15_suppl.e24050.Peer-Reviewed Original ResearchDual-energy X-ray absorptiometryChronic lymphocytic leukemiaFragility fracturesCumulative incidenceBone mineral density screeningComplications of osteoporosisUse of bisphosphonatesRoutine health maintenanceX-ray absorptiometryWilcoxon rank sum testChi-square testRank sum testCumulative incidence functionBisphosphonate useBaseline characteristicsMedicare 5Adverse outcomesBMD screeningTreatment advancesGray's testChronic cancerMedicare patientsDXA useLymphocytic leukemiaHigh risk
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply